CPRX vs XPEV · P/E 18, rev $491.7M vs rev $895.7M
Catalyst Pharmaceuticals Inc (CPRX) versus Xpeng Inc (XPEV) — a side-by-side from cached financials, not a winner call.
Catalyst Pharmaceuticals Inc (CPRX) is a biotechnology company listed on NASDAQ.
Xpeng Inc (XPEV) is a auto manufacturers company listed on US. It is led by Xiaopeng He.
Latest reported CPRX revenue for 2024-12-31 was $491.7M. Net income was $163.9M. Revenue was up 23.5% from 2023-12-31 to 2024-12-31. CPRX currently screens at market cap $3.84B and trailing P/E 18.2.
Latest reported XPEV revenue for 2020-12-31 was $895.7M. Net income was -$418.7M. XPEV currently screens at market cap $20.28B.
CPRX currently screens at market cap $3.84B and trailing P/E 18.2. XPEV currently screens at market cap $20.28B.
Not investment advice. Open the CPRX and XPEV stock pages for the full models.
Not investment advice.